High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke

Disease Markers

Volumn 26, Issue 4, 2009, Pages 189-195

  Rodríguez Yáez, Manuel ^a   Sobrino, Tomás ^a   Blanco, Miguel ^a   De La Ossa, Natalia Pérez ^b   Brea, David ^a   Rodríguez González, Raquel ^a   Leira, Rogelio ^a   Dávalos, Antonio ^b   Castillo, José ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Brain natriuretic peptide; Cardioembolic stroke; Ischemic stroke; Ischemic stroke classification

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB;

AGED; ALGORITHM; ARTICLE; BLOOD SAMPLING; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HEART MUSCLE INJURY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE;

EID: 70349097630     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0630     Document Type: Article

References (33)

1. H.P. Adams Jr., B.H. Bendixen, L.J. Kappelle et al., Classifi-cation of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial, TOAST, Trial of Org 10172 in Acute Stroke Treatment, Stroke 24 (1993), 35-41.
2. F.S. Apple, M. Panteghini, J. Ravkilde, J. Mair, A.H. Wu, J. Tate, F. Pagani, R.H. Christenson and A.S. Jaffe, Committee on Standardization of Markers of Cardiac Damage of the IFCC, Quality specifications for B-type natriuretic peptide assays, Clin Chem 51 (2005), 486-493.
3. A. Arboix, L. García-Eroles, J.B. Massons, M. Oliveres, R. Pujades and C. Targa, Atrial fibrillation and stroke: clinical presentation of cardioembolic versus atherothrombotic infarction, Int J Cardiol 73 (2000), 33-42.
4. C. Bell and M. Kapral, Use of ambulatory electrocardiography for the detection of paroxysmal atrial fibrillation in patients with stroke, Canadian Task Force on Preventive Health Care, Can J Neurol Sci 27 (2000), 25-31.
5. M.R. Cowie and G.F. Mendez, BNP and congestive heart failure, Prog Cardiovasc Dis 44 (2002), 293-321.
6. E. Di Angelantonio, S. De Castro, D. Toni, M.L. Sacchetti, F. Biraschi, M. Prencipe and M. Fiorelli, Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA, J Neurol Sci 260 (2007), 139-142.
7. G. Fabinyi, D. Hunt and L. McKinley, Myocardial creatine kinase isoenzyme in serum after subarachnoid hemorrhage, J Neurol Neurosurg Psychiatry 40 (1977), 818-820.
8. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich and M.J. Radford, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA 285 (2001), 2864-2870.
9. G. Giannakoulas, A. Hatzitolios, H. Karvounis, G. Koliakos, A. Charitandi, T. Dimitroulas, C. Savopoulos, E. Tsirogianni and G. Louridas, N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke, Angi-ology 56 (2005), 723-730.
10. L.E. Hackenberry, M.E. Miner, G.L. Rea, J. Woo and S.H. Graham, Biochemical evidence of myocardial injury after severe head trauma, Crit Care Med 10 (1982), 641-644.
11. A. Hammerer-Lercher, E. Neubauer, S. Müller, O. Pachinger, B. Puschendorf and J. Mair, Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction, Clin Chim Acta 310 (2001), 193-197.
12. J.K. Jensen, L. Korsholm, P.F. Hilund-Carlsen, D. Atar, S.R. Kristensen and H. Mickley, The relation between electrocardiographic ST-T changes and NT-proBNP in patients with acute ischemic stroke, Scand Cardiovasc J 41 (2007), 294-298.
13. M. Kaste, H. Somer and A. Konttinen, Heart type creatine kinase isoenzyme (CK MB) in acute cerebral disorders, Br Heart J 40 (1978), 802-805.
14. H.J. Lin, P.A. Wolf, E.J. Benjamín, A. Belanger and R.B. D'Agostino, Newly diagnosed atrial fibrillation and acute stroke, The Framingham Study, Stroke 26 (1995), 1527-1530.
15. C. Marini, F. De Santis, S. Sacco, T. Russo, L. Olivieri, R. Totaro and A. Carolei, Contribution of atrial fibrillation to incidente and outcome of ischemic stroke: results from a population-based study, Stroke 36 (2005), 1115-1119.
16. J. Montaner, M. Perea-Gainza, P. Delgado et al., Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers, Stroke 39 (2008), 2280-2287.
17. T. Mueller, A. Gegenhuber, B. Dieplinger, W. Poelz and M. Haltmayer, Long-term stability of endogenous B-type na-triuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples, Clin Chem Lab Med 42 (2004), 942-944.
18. M. Mukoyama, K. Nakao, K. Hosoda, S.I. Suga, Y. Saito, Y. Ogawa et al., Brain natriuretic peptide as novel cardiac hormona in humans: Evidence for an exquisite dual natriuretic peptide system, atrial peptide and brain natriuretic peptide, J Clin Invest 87 (1991), 1402-1412.
19. M. Naruse, Y. Takeyama, A. Tanabe et al., Atrial and brain natriuretic peptides in cardiovascular diseases, Hypertension 23 (1994), I231-I234.
20. T. Naya, K. Yukiiri, N. Hosomi et al., Brain Natriuretic Peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation, Cerebrovas Dis 26 (2008).
21. J.W. Norris, V.C. Hachinski, M.G. Myers, J. Callow, T. Wong and R.W. Moore, Serum cardiac enzymes in stroke, Stroke 10 (1979), 548-553.
22. S. Palacio and R.G. Hart, Neurologic manifestations of cardio-genic embolism, An update, Neurol Clin 20 (2002), 179-193.
23. P.R. Puleo, P.A. Guadagno, R. Roberts, M.V. Scheel, A.J. Marian, D. Churchill and M.B. Perryman, Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB, Circulation 82 (1990), 759-764.
24. A.M. Richards, M.G. Nicholls, T.G. Yandle, C. Frampton, E.A. Espiner, J.G. Turner, R.C. Buttimore, J.G. Lainchbury, J.M. Elliott, H. Ikram, I.G. Crozier and D.W. Smyth, Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin, New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction, Circulation 97 (1998), 1921-1929.
25. Y. Sato, H. Maruoka, Y. Honda, N. Hachiya and K. Oizu-mi, Plasma concentrations of atrial natriuretic peptide in cardioembolic stroke with atrial fibrillation, Kurume Med J 42 (1995), 71-77.
26. T. Sudoh, K. Kangawa, N. Minamino and H. Matsuo, A new natriuretic peptide in porcine brain, Nature 332 (1988), 78-81.
27. K. Tsuchida and K. Tanabe, Influence of paroxysmal atrial fib-rillation attack on brain natriuretic peptide secretion, J Cardiol 44 (2004), 1-11.
28. N. Valli, A. Gobinet and L. Bordenave, Review of 10 years of the clinical use of brain natriuretics peptide in cardiology, J Lab Clin Med 134 (1999), 437-444.
29. P.A. Wolf, R.D. Abbott and W.B. Kannel, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke 22 (1991), 983-988.
30. A.H. Wu, A. Smith, S. Wieczorek, J.F. Mather, B. Duncan, C.M. White, C. McGill, D. Katten and G. Heller, Biological variation for N-Terminal Pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure, Am J Cardiol 92 (2003), 628-631.
31. A.H. Wu, A. Smith, S. Wieczorek, J.F. Mather, B. Duncan, C.M. White, C. McGill, D. Katten and G. Heller, Biological variation for N-Terminal Pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure, Am J Cardiol 92 (2003), 628-631.
32. H.K. Yip, C.H. Sun, L.T. Chang, M.C. Chen and C.W. Li-ou, Time course and prognostic value of plasma levels of N-terminal pro-Brain Natriuretic Peptide in patients after is-chemic stroke, Circ J 70 (2006), 447-452.
33. M. Yoshimura, H. Yasue, K. Okumura et al., Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure, Circulation 87 (1993), 464-469.